Allscripts-Misys Healthcare Solution (MDRX) Tops Q3 EPS by 2c, Raises FY11 Guidance
Tweet
Share
E-mailGet Alerts MDRX Hot Sheet
Join SI Premium – FREE
Allscripts-Misys Healthcare Solution (NASDAQ: MDRX) reported Q3 EPS of $0.25, $0.02 better than the analyst estimate of $0.23. Revenue for the quarter came in at $371.4 million versus the consensus estimate of $364.87 million.
Allscripts-Misys Healthcare Solution sees FY2011 EPS of $0.91-$0.93, versus prior guidance of $0.88-$0.90 and the consensus of $0.90. Allscripts-Misys Healthcare Solution sees FY2011 revenue of $1.455-$1.446 million, versus the consensus of $1.44 million.
Allscripts-Misys Healthcare Solution sees FY2011 EPS of $0.91-$0.93, versus prior guidance of $0.88-$0.90 and the consensus of $0.90. Allscripts-Misys Healthcare Solution sees FY2011 revenue of $1.455-$1.446 million, versus the consensus of $1.44 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
